Results 111 to 120 of about 16,628 (221)

The Prevalence of Hypersensitivity Reactions to Antirheumatic Biological Agents and Results of the Skin Tests: Experience of a Tertiary Referral Allergy Center in Turkey

, 2020
Ceyda Tunakan Dalgıç, Figen Yargucu Zihni, Gökten Bulut, Ali Kokuludağ, Aytül Sin   +4 more
openalex   +2 more sources

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis [PDF]

, 2012
Jasvinder A. Singh, Daniel E. Fürst, Aseem Bharat, Jeffrey R. Curtis, Arthur F. Kavanaugh, Joel M. Kremer, Larry W. Moreland, James R. O’Dell, Kevin Winthrop, Timothy Beukelman, S. Louis Bridges, W. Winn Chatham, Harold E. Paulus, María E. Suärez-Almazor, Claire Bombardier, Maxime Dougados, Dinesh Khanna, Charles M. King, Amye Leong, Eric L. Matteson, John T. Schousboe, Eileen Moynihan, Karen S. Kolba, Archana Jain, Elizabeth R. Volkmann, Harsh Agrawal, Sangmee Bae, Amy S. Mudano, Nivedita M. Patkar, Kenneth G. Saag   +29 more
openalex   +1 more source

Rationales for discontinuation of disease-modifying antirheumatic drugs, biologic agents, and tofacitinib in rheumatoid arthritis

, 2018
Yu. V. Muraviev, G. I. Gridneva, L. A. Muravieva, N. V. Muravieva, A. V. Alexeeva, К. S. Nurbaeva, K. M. Mikhailov, A. V. Rozov   +7 more
openalex   +2 more sources

NEW GUIDELINES FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE PLACE OF GLUCOCORTICOIDS

Научно-практическая ревматология, 2016
Despite major advances in the management of rheumatoid arthritis (RA), whicare associated with the development of new methods for its early diagnosis, the clinical introduction of a wide range of innovative medications and particularly the improvement of
E. L. Nasonov
doaj  

A Practical Procedure for the Synthesis of Esonarimod, (R,S)-2-Acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic Acid, an Antirheumatic Agent. (Part 1).

, 2002
Toshiya Noguchi, Akira Onodera, Kazuyuki Tomisawa, Sadakazu Yokomori   +3 more
openalex   +2 more sources

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

, 2011
Stefania Zingarelli, Paolo Airò, Micol Frassi, Chiara Bazzani, Mirko Scarsi, Massimo Puoti   +5 more
openalex   +2 more sources

Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis [PDF]

, 2013
G Sakellariou, Athanasios D. Anastasilakis, Ilias Bisbinas, Anastasios Gketsos, Charalampos Berberidis   +4 more
openalex   +1 more source

2. Antirheumatic Agents, 1) Non-biologic Agents

, 2012
Naoto Tamura
openalex   +2 more sources

THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry [PDF]

, 2017
Axel Finckh, Lisa Herzog, Almut Scherer, Jean Dudler, B. Moeller, A Ciurea, Ruediger B. Müeller, Paul Hasler, Pascale Exer, I. Von Muehlenen, Diego Kyburz, Cem Gabay, Pascal Zufferey   +12 more
openalex   +1 more source

Relationship between biologic therapy and cytokine levels in patients with inflammatory arthritis. [PDF]

Medicine (Baltimore)
Zhang Z, Zhou BH, Hu L, Li MC, Chang D, Dou X.   +5 more
europepmc   +1 more source